July 28, 2006 - ApoPharma, manufacturer of the oral chelator Ferriprox (deferiprone) will host a series of webcasts on the topic "Combination Therapy in Thalassemia: A Review of Treatment Strategies to Maximize Patient Outcomes." The dates for the webcasts are:
Tuesday, September 12 - 11:00 am GMT (7:00 am EDT)
Wednesday, September 13 - 4:00 pm GMT (12:00 noon EDT)
Thursday, September 14 - 5:00 pm GMT (1:00 pm EDT)
Renzo Galanello, MD, Professor of Pediatrics at the University of Cagliari in Italy, will be the presenter for the webcasts. He will answer questions following each presentation.
The advertisement for the webcasts lists the following objectives:
Understand the rationale for selecting combination therapy as a treatment option for thalassaemia major patients
Learn how different iron chelators can be used in combination therapy
Gain insight into combination therapy treatment strategies
Review the most recent clinical data for optimizing the use of iron chelators in combination
To register for the webcasts, go to
www.ferriprox.org, enter the website and click on the "webcast" icon.
PS: If you have any questions about "WEBCAST" - how to attend this online webcast from your computer - just post your questions here and I will be able to help you out with it.
Thanks
Admin
Linear Mode
